The present disclosure relates generally to the field of medical devices. More specifically, the present disclosure relates to a mobile Electrocardiogram (“ECG”) system and method of use.
There are 700-750,000 heart attacks in the United States annually, of which 210,000 are recurrent events. In addition, 8-10 million patients visit the emergency room (“ER”) annually for chest pain. Through the process of interviewing practicing clinicians, it is readily apparent that there are numerous recurrent visits to the ER. These result in costly hospital stays for patients who have had myocardial infarction (“MI”). There is a push by the insurance and hospital industries to reduce these visits, as well as other “unnecessary” visits to the ER. Of all the chest pain (“CP”) visits to the ER, only 0.06% are true life-threatening emergencies once per prognosticator indicators have been accounted for.
The consequences of each CP visit to the ER are psychological, as well as direct and indirect economic costs. Once a patient has had an acute coronary syndrome (“ACS”) event, especially at a young age (under 65 y/o), the psychological ramifications are significant. Those patients typically live in fear of their cardiac status and the fear of having another myocardial infarction (“MI”). This effect also spills over to their immediate friends, family and co-workers, some of whom may become worried about their own mortality. Post-MI depression occurs affects 1 in 6 patients and 2 out of every 6 patients have some signs/symptoms of depression leading to increased mortality rates within the first 6 months. According to various medical sources, up to 12% of the post-ACS patients develop Post-Traumatic Stress Disorder (“PTSD”) which results in a doubling of their risk of another ACS event and mortality within 1-3 years.
The economic implications of chest pain are quite significant. Table 1 demonstrates the potential economic damages to the patient from an unnecessary visit to the ER:
These prices are approximate depending on the patient's health plan. Many patients must meet deductibles of $2500-$6000 before their insurance covers the cost of an ER visit or even an observation stay in the hospital.
Cost to Hospitals:
1. Economic loss from extended stays:
Societal Cost (See Appendix 2, Indirect cost projections to 2035):
The goals of the US healthcare system are to reduce the cost of care, expedite care, reduce length of stay in the hospital, and reduce readmission rates while maintaining quality of care. This includes maintaining low complication rates and improving patient satisfaction
In order to do so, hospitals across the US have been providing value added services at their own expense, such as telehealth services for congestive heart failure (“CHF”) management. The current reimbursement model results in a very low profit margin for chest pain services. Thus, anything a hospital can do to reduce unnecessary admissions is in its best interest.
The unsettled and rapidly expanding space is the world of wearables technology provides immediate biofeedback to the wearer. By various estimates, the mHealth (mobile health) market is poised to grow into a multi-billion dollar industry. Still in its infancy, advancements in micro-technology, micro-processing, and software development allow innovators to develop products which were either only dreamed about 10-20 years ago or allow legacy devices to be miniaturized and repurposed for mobile platforms. Those individuals willing to be engaged will find a supply of products to meet many of their healthcare needs. The thrust for these devices is to liberate patients from costly tests, reduce financial burdens on the patient and healthcare system, and create an environment which motivates individuals to adhere to a prescribed regimen. Accordingly, these and other needs are addressed by the mobile ECG system of the present disclosure.
This present disclosure relates to a mobile ECG system and method of use. The system includes a portable, easy-to-use ECG device that allows users to record ECG data, and to transmit the ECG data to a user device. Additionally, the system provides for a cloud-based storage system capable storing the ECG data and providing access to the ECG data to the user and to medical personal.
The ECG system in accordance with the present invention includes a mobile ECG device designed to provide medical-quality tracings at a cost affordable to the average American. Unlike the traditional 12-lead ECG, the ECG device can be a 9-lead system which would capture the majority of acute coronary syndromes by coupling ECG data with interactive software which together would risk stratify the need for emergent medical care. Utilizing the ability to compare serial ECGs and being able to accurately assess changes in the ST-segment and T waves along with the input of symptoms and basic vital signs, the ECG system would capture the majority of heart attacks as well as assisting in differentiating cardiac from non-cardiac chest pain so that the user is able to make an educated decision on whether or not a visit to the ER is warranted. This is accomplished by utilizing evidence-based algorithms which have already been incorporated into current clinical practices.
The ECG system is generally designed with simplicity in mind. For the limb leads, either a 4-bracelet system, 1 for each wrist, and 1 for each ankle can be used. Also, the Mobile ECG system can be designed using a zero-bracelet, a 2-bracelet and 3-bracelet system.
The signal processing used in the ECG system can be incorporated into a chest plate housing with wireless electrocardiographic transmission to a user device, such as a smart phone, tablet or laptop. An additional iteration of the ECG system can include a separate processing unit which will be connected either wirelessly or by wire. The processing unit can be configured to transmit the electrocardiogram to the user device. In addition, due to the chest device, the ECG system can be configured to monitor and/or measure the respiratory rate of the wearer.
The ECG system is configured to utilize the electrocardiographic data and compare such data with prior electrocardiographic data and provide a comparison by analyzing such measurements from the user. In addition, the ECG system can be configured to display the respiratory rate of the user.
The ECG device, through the utilization of modern technology, redesigns and reinvents the ECG machine to provide complete portability. The ECG is a critical component of the diagnostic portfolio, currently available only in the ER/hospital setting or a physician's office.
In the short term, the ECG demonstrates irreplaceability through the accuracy of its ECG tracing and comparison capabilities and the accuracy of its risk stratification capacity through a learning interactive algorithm. Customer retention and improvement follows through continued hardware and software improvements. Service line expansion occurs by offering a cheaper device with limited capabilities but enhanced software for chronic disease state management.
Currently, no commercially available devices/systems address this issue. There are multiple manufacturers of single-lead ECG systems which monitor only basic arrhythmia and heart rate monitoring; such systems are inadequate to assist in the differentiation of cardiac from non-cardiac chest pain. Home telehealth companies currently utilize Bluetooth-connected oximeters, scales, and blood pressure cuffs for CHF patients. The information is sent to a monitoring center and requires a nurse to review the data, review the information with the patient's physician, and then guide the patient on medication changes.
The foregoing features of the invention will be apparent from the following Detailed Description of the Invention, taken in connection with the accompanying drawings, in which:
The present disclosure relates to a mobile Electrocardiogram (“ECG”) device and method of use, as described in detail below in connection with
The network 16 can be any type of wired or wireless network, including but not limited to, a legacy radio access network (“RAN”), a Long Term Evolution radio access network (“LTE-RAN”), a wireless local area network (“WLAN”), such as a WiFi network, an Ethernet connection, or any other type network. The ECG device 12 can be connected to the user device 14 via a wireless network connection (e.g., Bluetooth, WiFi, LTE-RAN, etc.) or a direct wired connection between the ECG device 12 and the user device 14 (e.g., a wired universal serial bus (USB)) connection. Optionally, mobile ECG device 12 and the user device 14 could communicate with a remote server 20. The remote server 20 can be any type of server used for data storage, such as, for example, a hard drive, a cloud storage repository (e.g., Dropbox, Google Drive, etc.), etc. The remote server 20 can receive data via the network 16 from the ECG device 12 and the user device 14.
The WiFi transceiver 32 could include any suitable, commercially-available transceiver configured to transmit and/or receive data via a WiFi frequency band, and which enables communication with other electronic devices directly or indirectly through a WiFi network based upon the operating frequency of the WiFi network. The Bluetooth transceiver 34 could include any suitable, commercially-available transceiver configured to transmit and/or receive data via a Bluetooth connection, and which enables communication with other electronic devices directly or indirectly through a Bluetooth connection based upon the operating frequency of the Bluetooth wireless technology standard. It be understood that the ECG device 12 can include either or both of the transceivers (WiFI transceiver 32 and Bluetooth transceiver 34), or any other suitable transceivers, such as, but not limited to, Zigbee transceivers, LTE transceivers, 3G legacy transceivers, etc.
The ECG lead port 36 could include any suitable port for connecting an ECG lead system to the ECG device 12. The ECG lead system includes one or more leads 18 connected to an electrical connection clip on one end (e.g., an octopus cable), and a mean to connect to one or more electrodes on the other end (e.g., an alligator clip). The electrical connection clip can be inserted into the ECG lead port 36. Each electrode can be placed on a patient's limbs (e.g., arms and legs), or chest. The ECG lead system can comprise any number of leads 18 producing any number of channels output. For example, the ECG lead system can include 10 leads producing a 12 channel output, 7 leads producing a 9 channel output, which is expandable to a 12 channel output (e.g., 6 limb lead output: aVR, aVL, aVF, I, II, III; chest leads: V2, V3, V4 expandable to V1, V2, V3, V4, V5, V6), etc.
For limb leads, a bracelet system can be used, such as, for example, 4-bracelet system, a zero-bracelet, 2-bracelet, and 3-bracelet system. The 4-bracelet system can include one lead for each wrist and one lead for each ankle. The zero-bracelet system can be in the form of a fully wearable chest piece with all of the necessary leads incorporated into a chest and abdomen plate. In this arrangement, 3-5 precordial leads can be used in addition to an extension towards both shoulders and both hips so as to complete the zero bracelet system. The 2-bracelet system can include a bracelet for each ankle and the chest piece can house 3-5 precordial leads and have two extensions, one towards each shoulder for the remaining limb leads. The 3-bracelet system can include a chest piece with 3-5 precordial leads and an extension lead towards either the right or left shoulder along with one bracelet for either the right or left wrist and one bracelet for each ankle. The chest piece can include chest patches which include adjustable components for body sizing and location placement.
Alternatively, the electrodes can each comprise wireless functionality where each electrode transmits ECG data wirelessly to the ECG device 12 or the user device 14. For example, each electrode, bracelet and chest piece can comprise a processor and/or a wireless transceiver (e.g., Bluetooth transceiver, WiFi transceiver, etc.) or transmitter to transmit the ECG data to a transceiver in the ECG device 12 or in the user device 14.
The other components 38 can be a battery, wireless charging device, a power port/cable, an audio output device, an audio input device, a data acquisition device, a USB port, one or more further ports to electronically connect to other electronic devices, a respirometer body temperature sensor, an oxygen sensor, a blood pressure sensor, a global positioning system (“GPS”) device, a movement/motion accelerometer, a body weight/fat sensor, etc.
By way of example, the ECG device 12 can include a chest patch with a wire extension toward a left shoulder and from the left shoulder to a right shoulder, another wire extension from a chest patch towards a left hip and from the left hip towards a right hip. The ECG device 12 can connect to the chest patch. By way of another example, the ECG device 12 can be incorporated into a wearable clothing item or other sleeve/accessory design with integrated sensors and transmitters with adjustments for different body sizing.
The ECG application 46 is a software application (“app”) that can communicate with the user device 14 via, for example, a Bluetooth or a WiFi wireless connection. The ECG application 46 can also perform other functions, such as initiate a connection pairing, receive user inputs, transmit the user inputs to the ECG device 12, receive data from the ECG device 12, manage the data, change parameters of the ECG device 12 or the ECG application 46, show an electrocardiogram received from the ECG device 12, receive ECG data from a third party, etc. Additionally, the ECG application can store data collections, surveys, psychological states, recommended diets/exercises, patient diets/exercises, medications, medical histories, symptoms, activities, lifestyles, recommend proper leads/sensor placements, etc. These functions will be explained in greater detail below. The ECG application 46 can have security features for ensuring HIPPA compliance, including data encryption and user identity.
The display device 48 can be a hardware component configured to show data to a user. The input/output device 50 can be a hardware component that enables the user to enter inputs. The display device 48 and the input/output device can be separate components or integrated together, such as a touchscreen.
The cellular transceiver 52 is a hardware component configured to transmit and/or receive data via a cellular connection. Specifically, the cellular transceiver 52 enables communication with other electronic devices directly or indirectly through a cellular network (e.g., an LTE network, a legacy network, etc.) based upon the operating frequency of the cellular network.
The WiFi transceiver 54 could include any suitable, commercially-available transceiver configured to transmit and/or receive data via a WiFi frequency band, and which enables communication with other electronic devices directly or indirectly through a WiFi network based upon the operating frequency of the WiFi network. The Bluetooth transceiver 56 could include any suitable, commercially-available transceiver configured to transmit and/or receive data via a Bluetooth connection, and which enables communication with other electronic devices directly or indirectly through a Bluetooth connection based upon the operating frequency of the Bluetooth wireless technology standard.
The other components 58 can include a battery, an audio output device, an audio input device, a data acquisition device, one or more ports to electronically connect to other electronic devices, etc. The process steps of the invention disclosed herein could be embodied as computer-readable software/firmware code executed by the user device 14, and could be programmed using any suitable programming languages including, but not limited to, C, C++, C#, Java, Python or any other suitable language without departing from the spirit or scope of the present disclosure.
If the ECG device 12 is not connected to or paired with the user device 14, the ECG device 12 can store the ECG data until a connection or a pairing is performed with the user device 14. In another example, the ECG device 12 can transmit the ECG data to the remote server 20. In step 78, after the ECG data has been transmitted to the user device 14 or the remote server 20, the ECG device 12 can delete the ECG data from the memory 24. Alternatively, the ECG device 12 can maintain the ECG data in the non-volatile memory 26 until a user input or predetermined condition occurs. The predetermined condition can include reaching a storage capacity threshold value, exceeding a time duration, etc.
In function 104, the user 102 can perform a new user/patient/physician registration. In an example, the registration process can require an email account, a social security number, a national provider identification (“NPI”) number, a physician identification number (“UPIN”), etc. In function 106, the user 102 can perform a physician login. For example, the physician login can require a user name/password, a UPIN, etc. In function 108, the user 102 can update a patient profile. For example, the user 102 can update general profile information (address, height/weight, etc.) a user health history, general health details, etc.
In function 110, the ECG application 46 displays ECG data and provides searching and filtering capabilities. Specifically, in function 122, the user 102 can view previous ECG data from a selected date/time. In function 124, the user 102 can search/filter ECG signal data. In function 126, the user 102 can view (display) a current ECG waveform. In function 128, the user 102 can compare ECG data/waveforms from different readings.
In function 112, the user 102 can complete a patient questionnaire In function 114, the user 102 can perform ECG signal capture function and internet-of-thing (“IoT”) device integration. Specifically, the user 102 can connect the ECG application 46 with the ECG device 12 (via, for example, a Bluetooth connection) and receive data from the ECG device 12. More specifically, in function 130, the user 102 can perform a new ECG data capture, comprising, receiving ECG signals/data from the ECG device (function 132), extracting key metrics from the signals/data (function 134), generating calculated values (function 136), storing the ECG signals/data (function 138), and correlating the ECG signals/data (function 140). Additionally, the ECG application 46 can further allow physicians to locate patients, view ECG data authorized by the patients, and provide comments on the patients' ECG data.
The ECG signal analysis function 160 includes a generated waveform for a selected date function 182, a historical signal data analysis function 184, a search and filter ECG data runs function 186, and an analyze captured signal data (live) function 188. The IoT cloud integration function 162 includes a create IoT hub on a cloud computing platform (e.g., Microsoft Azure) function 192, a send ECG signals to IoT hub function 194, and a send key ECG analytics to IoT hub function 196. The IoT device integration function 164 includes an integrate with IoT device function 202, a generate calculated values function 204, a receive ECG signals from IoT device function 206, and an extract ECG metrics from IoT device function 208.
Selecting the “Live ECG Capture” button 354 will display the screen shown in
In an example, the ECG device 12 can connect directly to the network 16 via a LTE or WiFi connection, and comprise the ECG application 46. As would be understood by those skilled in the art, the ECG device 12 would be capable of performing the methods and function discussed above with regards to the user device 12. Thus, a need to pair the ECG device 12 to the user device 14 would be eliminated, as the ECG device 12 can perform the all of the combined functions of the ECG device 12 and the user device 14.
The system 10, via any or any combination of ECG device 12, the user device 14, and the server 20 can identify possible issues through a scoring algorithm or a risk score, such as, a low/medium/high risk or likelihood of having a cardiac condition, or other conditions. Additionally, critical values measured by the system 10 can be marked as low/medium/high risk. This can allow a user to determine whether to seek urgent medical attention. The scoring algorithms/risk scores can include a score involving platelet glycoprotein IIb/IIIa in unstable angina receptor suppression using Intergrilin (eptifibatide) therapy, a thrombolysis in myocardial infarction score, a global registry of acute coronary events score, a fast revascularization in instability in coronary disease score, a score related to heart history, ECG, age, risk factors and troponin, or any other suitable algorithm or risk score.
The system 10 can further provide advanced analytics and business intelligence solutions. For example, the system 10 can provide a visualization of data and information through dashboards, graphs, charts, visual key performance indicators (“KPI”), trends, etc. Further, the system can provide a cognitive and artificial intelligence platform capable of creating advanced machine learning algorithms to detect and identify trends, issues, predictions regarding the user's health status, utilizing proprietary and public domain algorithms (e.g., a stable chest pain assessment algorithm) with continuous learning capabilities, etc. The data and information can be stored in the server 20 or in the user device 14, and can be shared with medical personal, including, for example, hospitals, doctors, administrators, nurses, insurance agencies, etc. For example, a user can transmit the data and information to a doctor prior or during a checkup appointment.
The IoT cloud 474 platform includes data storage system 492, a data analysis system 494, a disease warning system 496, and a data cleaning system 498. The data storage system 492 can be any type of storage system, including, but not limited to the server 20. For example, the data storage 492 can include a Cosmos database, which is a cost-effective service that stores the data that IoT devices send to the cloud. The database stores large meter data and supports flexible data format to derive insights, and follows semi-structured model to easily combine various device types having differing data schemes.
The data analytics system 494 can be any type of analytics system, such as those discussed in the present disclosure regarding analyzing ECG data. For example, the data analysis system 494 can include use a real-time analytics service, such as Stream Analytics, to help in the detection of anomalies and retrieval of archived data from smart meters/devices. The analytics service allows to write stream processing logic in a language similar to SQL from the data derived from the connected devices and forwards the extracted results to the event hub, a business analytics service (e.g., Power BI) and table storage services
The disease warning system 496 can be any type of system to warn a user or medical professional of a disease risk to the user (e.g., a low/medium/high risk or likelihood of having a cardiac condition, etc.) The data cleaning system 498 can be any type of system to detect and correct (or remove) corrupt or inaccurate records from a record set, a table, a dataset, etc. The IoT cloud 474 can communicate wirelessly with medical professionals 500 or with the graphical user interface 476, which includes a mobile app 502 (e.g., ECG application 46 or any other mobile app) and the Internet 504 (e.g., a website, a web app, etc.). The web apps and mobile apps, part of app service, help in hosting a web application used for configuring and sending commands to devices (e.g., the ECG device 12, the user device 14, the leads 18,), inspecting the data dashboard, creating or updating business logic and perform several events-driven functions.
It is noted that the IoT-based ECG monitoring system 470 can be categorized into six layers, which include smart device and controllers (e.g., ECG sensors), connectivity and protocol communication, an IoT hub, a cloud server, data storage and accumulation, data analysis and computing, and user applications and report generation. The IoT hub is a key component of any IoT solution. It primarily serves as a cloud gateway that connects all the ECG devices with the cloud and establishes communication between them. It can scale to connect millions of meters and can process huge volumes of data. It supports multiple protocols such as http, AMPG, MQTT to enable control and command capabilities. It is also responsible for per-device authentication, thus playing a major role in security aspects. The IoT hub also provides secure communication between ECG and user devices, and the cloud platform. Other systems that can be used include a message broker, used to connect systems and receive messages, and a rules engine(s), which can processes messages and provide an intergration mechanism with other services/systems, such as the databases.
The IoT-based ECG monitoring system 470 can include an event hub, which handles millions of events every second to stream the events into various applications. Variable load profiles like connected devices, mobile apps, application performance counters generate telemetry data periodically and/or in real time. The event hub consumes these events to accommodate numerous load profiles and process massive amounts of data
The IoT-based ECG monitoring system 470 can further enable transformation of collected data into intelligence using, for example, a machine learning system (e.g., Azure ML, etc.). The machine learning system offers limitless scalability, availability and unmatched security. Also, the machine learning system generates powerful insights for real-time and predictive analytics, helps in fixing resilient & persistent issues, and makes reliable predictions, which can help the utility operations team and the consumers to become aware of utility usage.
The following additional analysis information is provided to further highlight the benefits and advantages of the ECG system of the present disclosure.
Political:
The political climate has been dictating cheaper and faster care with a reduction in cost, length of stay, and readmissions. Medical care spending comprises nearly 18% of the US GDP.
The Affordable Care Act (ACA) continues to be an economic burden and may become unsustainable. Recent projections by the Congressional Budget Office expect the majority of individuals enrolled in an insurance program to be those in the Medicaid pool, whereas private insurance enrollments will decrease. This raises a concern as to the sustainability of the ACA. Current politicians are looking to amend the ACA in order to reduce costs and provide a modified bill which meets the short-term and long-term needs of the American people without bankrupting the country.
Economic:
According to the Institute for New Economic Thinking, the ACA's expenses are skewed such that the sickest 10% of the patients utilize nearly ⅔ of every healthcare dollar. The cost per person (of the sickest patient) is approximately 54,000/yr. The remaining 90% of the patients cost an average of 6000/yr.
The ECG system offers a low cost solution to help reduce the number of ER visits for all chest pain patients, and especially those who have had a prior cardiac issue.
Societal:
At a biomedical level, the ECG system offers data very similar to a traditional 12-lead ECG. However, correlation through clinical trials is needed to validate the data. Society's challenge is accepting proof of concept that a system capable of learning symptoms, risk factors, physical exam, and ECG data provides feedback as an adjunct to that of a clinician.
Other societal benefits come from fewer days lost from work and less stress on patient support systems such as friends/family.
Societal challenge: clinical risk through poor performance
Technological:
As with any mobile health platform, cybersecurity and patient privacy are of concern.
The data obtained from each patient must be scrutinized carefully as it will be a skewed/biased population based on disease state or disease concern. Improvements in algorithmic assessments should be based on scientifically validated and accepted data.
Currently, the European Union and the Food and Drug Administration (FDA) are actively working on policies and procedures to regulate new mobile health technology. Currently the FDA grants device approvals via a 510(k) pathway. This pathway allows new technology to prove equivalence to pre-existing technology.
Environmental:
By reducing patient visits to the ER, with a downstream effect of reducing admissions, there will be a reduction in energy consumption as well as waste. The ECG system not only has a direct impact on the environment, but the long term effect of a cleaner environment is a healthier community.
T-M-O Analysis:
As a new player in the wearables market, the ECG system's niche for exploitation is the diagnostic algorithm space integrated with risk stratification to assist in the triage process.
Currently, the only ECG monitoring devices available for mobile use are single-lead systems for the lay person which are able to evaluate heart rhythms and 2-3-lead systems which are intended for physicians to prescribe for use on patients for the purpose of arrhythmia detection.
Today, a 9-lead system with an app designed to help provide triage-related advice does not exist. The ECG system, at this time, is the initial company in this segment of the wearables market, thereby giving it a first mover advantage.
Early competitors include Cardionet, LifeWatch®, Cardiostaff, Medtronic, and AMI-cardiac monitoring. All of these systems are 2-3-channel systems and monitor for arrhythmias only with the exception of LifeWatch® which performs ST segment monitoring as well. Qardio and Omron arrhythmia monitors are designed for the layperson coupled with a mobile app and are single lead systems only. The Omron system is not a wearable
Having thus described the system and method in detail, it is to be understood that the foregoing description is not intended to limit the spirit or scope thereof. It will be understood that the embodiments of the present disclosure described herein are merely exemplary and that a person skilled in the art may make any variations and modification without departing from the spirit and scope of the disclosure. All such variations and modifications, including those discussed above, are intended to be included within the scope of the disclosure. What is intended to be protected by Letters Patent is set forth in the following claims.
This application claims the benefit of U.S. Provisional Patent Application No. 62/638,590 filed Mar. 5, 2018, the entire disclosure of which is expressly incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62638590 | Mar 2018 | US |